Scancell : Interim Report 31st October 2023
CHIEF EXECUTIVE OFFICER'S STATEMENT I am pleased to report the Group's interim results for the six-month period ended 31 October 2023. During the period, Scancell...
Stay updated with breaking news from Scancell Moditope. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHIEF EXECUTIVE OFFICER'S STATEMENT I am pleased to report the Group's interim results for the six-month period ended 31 October 2023. During the period, Scancell...
Key highlights for biotech group Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)’s financial year ending 30 April 2023 included a positive data reading arising...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing groundbreaking immunotherapies, is set to showcase early promising results from its ModiFY...
Immunotherapy developer Scancell said on Friday that it is set to present an informative poster at the American Society of Clinical Oncology Meeting (ASCO) 2023 annual meeting in Chicago from 2 to 6 June.
Deep Dive - Scancell Holdings PLC